KIN - Kindred Biosciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $3.08. This is a potential upside of $3.08 (0%) from yesterday's end of day stock price of $0.

Kindred Biosciences's activity chart (see below) currently has 39 price targets and 33 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50.3% with an average time for these price targets to be met of 183 days.

Most recent stock forecast was given by BEN HAYNOR from ALLIANCE GLOBAL PARTNERS on 23-Aug-2021. First documented stock forecast 17-Nov-2015.

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 23-Aug-2021

$15.25

4 years 4 months 12 days ago
(23-Aug-2021)

2/4 (50%)

$10.95 (254.65%)

332

Hold

Since 17-Jun-2021

4 years 6 months 18 days ago
(17-Jun-2021)

2/4 (50%)

$4.96 (35.33%)

30

Hold

Since 16-Jun-2021

$9.25

$11

4 years 6 months 19 days ago
(16-Jun-2021)

1/5 (20%)

$0.02 (0.22%)

69

Hold

Since 16-Jun-2021

$9.25

4 years 6 months 19 days ago
(16-Jun-2021)

1/2 (50%)

$0.02 (0.22%)

69

Buy

Since 22-May-2019

$9

$-0.25 (-2.70%)

$13

4 years 7 months 23 days ago
(12-May-2021)

1/3 (33.33%)

$4.7 (109.30%)

35

Show more analysts

Please expand the browser size to see the chart

What is KIN (Kindred Biosciences) average time for price targets to be met?

On average it took 183 days on average for the stock forecasts to be realized with a an average price target met ratio 50.3

Which analyst has the current highest performing score on KIN (Kindred Biosciences) with a proven track record?

ALEX ARFAEI

Which analyst has the most public recommendations on KIN (Kindred Biosciences)?

Alex Arfaei has 5 price targets and 6 ratings on KIN

Which analyst is the currently most bullish on KIN (Kindred Biosciences)?

Brooks O'neil with highest potential upside - $2.75

Which analyst is the currently most reserved on KIN (Kindred Biosciences)?

Alex Arfaei with lowest potential downside - -$4.25

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?